A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Cook Medical Provides Patient-Level Paclitaxel Data From Randomized Control Trial

Paclitaxel Data From Randomized Control Trial: This week, Cook Medical made patient-level data from the Zilver® PTX® randomized control trial (RCT) available by request on COOK Medical’s website. Cook provides this data to encourage further collaboration with researchers to benefit patients with peripheral arterial disease.

“We will continue to support our customers and their patients by sharing what we’ve discovered from our research and data in the area of paclitaxel,” said Mark Breedlove, vice president of Cook Medical’s Vascular Division.

Cook’s Zilver PTX RCT followed 479 patients over five years in the US, Germany, and Japan. Cook is the first company with paclitaxel devices to make de-identified patient-level data on these devices publicly available. To ensure privacy and confidentiality of the patients involved, Cook has reviewed the data provided and de-identified it as necessary to mitigate identification risk. The data is intended for non-commercial research purposes only and will be provided at no charge.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy